权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Novel Gene-Environment Regulatory Circuit in Chamber Specific Growth of Perinatal Heart

围产期心脏腔室特异性生长的新型基因-环境调节回路

基本信息

批准号：
10002601
负责人：
Marlin Touma
金额：
$ 39万
依托单位：
UNIVERSITY OF CALIFORNIA LOS ANGELES
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
起止时间：
2019-09-15 至 2020-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10002601
关键词：
Address Area Biological Boston CREB1 gene Cardiac Cardiac Myocytes Cardiac development Cardiovascular system Caring Cells Clinical Clinical Skills Common Ventricle Complement Congenital Heart Defects Critical Congenital Heart Defects DNA Sequence Alteration Development Doctor of Philosophy Environment Environmental Risk Factor Fellowship Fetal Growth Genes Genomics Goals Growth Growth and Development function Heart Heart Abnormalities Heart Research Human Hypoxemia Hypoxia In Vitro Infant Knockout Mice Knowledge Laboratories Lead Mediating Medicine Mentorship Molecular Molecular Biology Morphogenesis Mus Muscle Cells Mutation Neonatal Newborn Infant Outcome Study Oxygen Pathogenesis Pathologic Pathology Pathway interactions Pediatric Hospitals Pediatrics Perinatal Perinatal Hypoxia Phenotype Physicians Physiology Premature Infant Process RB1 gene Rattus Regulation Repression Research Research Personnel Research Proposals Research Training Residencies Right ventricular structure Role Sampling Scientist Signal Pathway Signal Transduction Specimen Stress Testing Tetralogy of Fallot Texas Training United States National Institutes of Health Universities Ventricular WNT Signaling Pathway Work cardiogenesis career clinically relevant congenital heart disorder fetal genome-wide analysis hemodynamics in vivo insight loss of function medical specialties mouse model neonate novel overexpression perinatal development perinatal medicine perinatal period preterm newborn professor programs receptor response skills stressor transcriptome

项目摘要

PROJECT SUMMARY/ABSTRACT This proposal describes a 5-year NIH/R01-Early Stage Investigator Application for the development of my academic and investigative career in neonatal cardiovascular medicine. I have completed a residency training in Pediatrics at University of Texas and a subspecialty fellowship training in Neonatal–Perinatal Medicine at Boston Children's Hospital, Harvard University. In 2015, I completed a PhD program in Molecular, Cell & Integrated Physiology, through the Specialty and Advanced Research Training (STAR) Program, at UCLA under the mentorship of Dr. Yibin Wang. In 2016, I transitioned to my independent laboratory to establish the Neonatal/Congenital Heart Research Program. Using the acquired skills in genomics and molecular biology combined with new insights learnt from my thesis research in neonatal heart maturation, I aim to develop a research program focusing on perinatal cardiac chamber growth and response to external stress in the context of congenital heart defects (CHDs). My research efforts have been complemented with my growing clinical skills in taking care of preterm infants and newborns with CHDs as an Assistant Professor of Pediatrics at Mattel Children's Hospital at UCLA. I am also the founder and the director of the CHD-BioCore at UCLA. Perinatal heart maturation and its regulatory network is a very much-understudied area of cardiac development, but with potential major implications in the care of neonates with CHDs. The proposed research focuses on the role of intercellular signaling in the developmental regulation of perinatal heart chamber maturation and responses to hypoxia during fetal to neonatal transition, an understudied, but critical, window for cardiac growth, particularly, in the context of a CHD. In my previous work, I set out to address this important gap of knowledge by employing genome-wide analysis of perinatal cardiac transcriptome. From these studies, I uncovered a novel circuit involving Wnt11 signaling and hypoxia in regulating chamber specific growth. I further established that Wnt11 regulates cardiomyocyte (CMC) proliferation likely through RB1 regulation during normal and hypoxic transition as well as in cyanotic CHDs. In this proposal, I plan to establish the pathological impact and the molecular basis mediating Wnt11/Rb1 regulation of chamber specific CMC proliferation in response to hypoxia. In AIM 1, I will determine the role of Wnt11/Rb1 signaling in perinatal cardiac chamber development and hypoxia response using newly generated inducible and CMC specific Wnt11 knockout mouse model in combination with perinatal hypoxia exposure. In AIM 2, I will discover Wnt11 interactome in neonatal CMC to dissect cell-autonomous signaling mechanisms mediating Wnt11 function. In AIM3, I will determine the biological relevance of the newly discovered signaling network in vivo and will establish the clinical relevance in CHDs. Accomplishing the proposed studies will establish a novel interactome between Wnt11 and hypoxia that may potentially lead to chamber specific approaches for newborns with CHDs. UCLA provides an ideal scientific environment to accomplish the proposed research and career goals as an independent physician–scientist.

项目总结/文摘